AL

Spineguard SAPAR Spineguard Stock Report

Last reporting period 31 Dec, 2023

Updated 08 Nov, 2024

Last price

Market cap $B

0.008

Micro

Exchange

XPAR - Euronext Paris

ALSGD.PA Stock Analysis

AL

Uncovered

Spineguard SA is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-43/100

Low score

Market cap $B

0.008

Dividend yield

Shares outstanding

31.714 B

Spineguard SA engages in the design and manufacture of medical devices for the spine. The company is headquartered in Vincennes, Ile-De-France. The company went IPO on 2013-04-29. The firm involves with the DSG (Dynamic Surgical Guidance) technology that concentrates on the placement of bone implants for the benefit of patients, surgeons, hospital staff, and healthcare systems. The DSG digital technology platform is a real-time surgical guidance work based on the measurement of local electrical conductivity of tissues without X-rays that includes PediGuard devices, the manual instruments capable of alerting surgeons in real time to potential pedicle or vertebral breaches. The technology is also implemented for the surgical robots to improve the safety, accuracy and autonomy.

View Section: Eyestock Rating